Gene · 1012
CDH13: cadherin 13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CDH13: cadherin 13. Genes, record 1012. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1012
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P55290 | Cadherin-13 | 713 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents74
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 18410 | P55290 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 22908 | P55290 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 2489 | P55290 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5803 | P55290 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5803 | P55290 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 22908 | P55290 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 18410 | P55290 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 10325 | P55290 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 26055 | P55290 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 2489 | P55290 | Espacenet |
1 to 10 of 74
See all 74 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,170
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CDH13 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 15 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 9 | 2025 |
| U10AA008401 | Collaborative Study on the Genetics of Alcoholism (COGA). | 9 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 7 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 7 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 6 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 5 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 5 | 2025 |
1 to 10 of 2,170Source NIH's project files
See all 2,170 nih grantsPapers2,718
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| α-Synuclein suppresses glioma progression through the CDH13-JNK/c-Jun pathway. | J Neurooncol | 2026 | 42678647 | PubTator, text mining | PubMed |
| Intragenic deletions from whole genome sequencing of 1054 suicide deaths. | Res Sq | 2026 | 42619972 | PubTator, text mining | PubMed |
| CDH13 Is Associated with Cellular Viability After Exposure to Ionizing Radiation Using Genome-Wide Screening. | Int J Mol Sci | 2026 | 42589482 | PubTator, text mining | PubMed |
| Comprehensive evaluation of angiogenesis-associated genes in papillary thyroid cancer using bulk RNA and single-cell sequencing data. | Eur Arch Otorhinolaryngol | 2026 | 42472943 | PubTator, text mining | PubMed |
| Integrative Observational and Genetic Evidence From the UK Biobank Supports Carotid Intima-Media Thickness as a Window Into Cardiac Remodeling. | J Am Heart Assoc | 2026 | 42396779 | PubTator, text mining | PubMed |
| Hypoxia-induced regulations of cell adhesion molecules and their implications for pathogenesis, diagnosis, and treatment of endometriosis. | Front Mol Biosci | 2026 | 42325436 | PubTator, text mining | PubMed |
| Ca13Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications. | Antibodies (Basel) | 2026 | 42200830 | PubTator, text mining | PubMed |
| Metabolic syndrome definitions and cardiovascular risk concordance in the Negrito population: Insights from lipid-derived risk indices, inflammation and endothelial biomarkers. | Medicine (Baltimore) | 2026 | 42152340 | PubTator, text mining | PubMed |
| Clinical Implications of Serum Matrix Metalloproteinase-12 and Tumor Cadherin-13 for Molecular Subtyping and Personalized Therapy in Lung Cancer. | J Vis Exp | 2026 | 42149859 | PubTator, text mining | PubMed |
| PCIF1 modulates glioblastoma cell migration and invasion by altering PI(3,4)P2 levels through the PI5-phosphatase INPP5B. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 42145053 | PubTator, text mining | PubMed |
1 to 10 of 2,718
See all 2,718 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1012
GET https://conductscience.org/api/genes/v1/1012/patents?page=2